Hypoxia-regulated non-coding RNAs in OSCC liquid biopsy: from molecular mechanisms to AI-driven precision oncology
Blood tests detecting cancer-related RNA changes may help catch oral cancers earlier and predict which treatments will work best.
This PubMed-indexed clinical trial examines Hypoxia-regulated non-coding RNAs in OSCC liquid biopsy: from molecular mechanisms to AI-driven precision oncology. The available abstract reports Oral squamous cell carcinoma (OSCC) is characterized by late-stage diagnosis and high recurrence rates Intratumoral hypoxia, driven by hypoxia-inducible factors 1α and 2α (HIF-1α/HIF-2α), orchestrates aggressive phenotypes including epithelial-mesenchymal transition (EMT), metabolic reprogramming, stemness.
What the study was
- Study design
- Clinical trial
- Population
- Human participants
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Frontiers in oncology
Why it surfaced
Conservative rapid triage: clinical trial, human evidence, and direct relevance to Early cancer detection.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.